Prescribing statins
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease
Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment
Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations
Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics
Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide
Prediction of in vivo drug–drug interactions from in vitro data
Suicide and self-harm following prescription of SSRIs and other antidepressants
General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class
Socioeconomic gradient in use of statins among Danish patients
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003
Calcium antagonists and deep gingival pockets in the population-based SHIP study
Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients
Trimethoprim–sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients
Mirtazapine-induced arthralgia
Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation
Topiramate in non-approved indications and acute myopia or angle closure glaucoma